Who owns YS BIOPHARMA CO LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ys Biopharma stock

Who bought or sold YS BIOPHARMA CO LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Clear Street 48k $1.9k 0% Jun 2025
 View chart
SkyView Investment Advisors 12k $0 0% Jun 2025
 View chart
Ancora Advisors 5.1k $7.070000 0% Sep 2025
 View chart
HGC Investment Management 5.0k $25.000000 0% Sep 2025
 View chart

Who sold out of Ys Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
LMR Partners Jun 2025 1.1M $42k
Toronto-Dominion Bank Jun 2025 1.0M $42k
Valliance Asset Management Jun 2025 750k $30k
Jane Street Jun 2025 498k $20k
Finepoint Capital Jun 2025 490k $20k
Millennium Management Jun 2025 425k $17k
Bracebridge Capital Jun 2025 232k $9.3k
Calamos Advisors Jun 2025 146k $5.3k
Q Global Advisors Jun 2025 131k $5.0k
Athos Capital Jun 2025 129k $132k
Whitebox Advisors Jun 2025 125k $5.0k
Two Sigma Securities Jun 2025 105k $4.2k
D. E. Shaw & Co Jun 2025 100k $4.0k
Saba Capital Management Jun 2025 97k $3.6k
Walleye Trading Advisors Jun 2025 95k $3.8k
Cantor Fitzgerald, L. P. Jun 2025 77k $3.1k
Deutsche Bank Aktiengesellschaft Jun 2025 75k $3.0k